Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer

Prostate

Volumn 72, Issue 4, 2012, Pages 351-360

  Maeda, Toshihiro ^a   Murata, Masaki ^a   Chiba, Hideki ^b   Takasawa, Akira ^a   Tanaka, Satoshi ^a   Kojima, Takashi ^a   Masumori, Naoya ^a   Tsukamoto, Taiji ^a   Sawada, Norimasa ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

CPE and castration resistant prostate cancer; tight junctions

Indexed keywords

CLAUDIN 3; CLAUDIN 4; CLOSTRIDIUM PERFRINGENS ENTEROTOXIN; ENTEROTOXIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER TISSUE; CELL STRUCTURE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CLOSTRIDIUM PERFRINGENS; COLORIMETRY; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; DRUG MECHANISM; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; RNA INTERFERENCE;

ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; CELLS, CULTURED; CLAUDINS; ENTEROTOXINS; EPITHELIAL CELLS; HUMANS; MALE; MICE; MICE, NUDE; PROSTATE; PROSTATIC NEOPLASMS; RNA INTERFERENCE; TIGHT JUNCTIONS; TREATMENT OUTCOME; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84856037260     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21436     Document Type: Article

References (34)

1. Grönberg H,. Prostate cancer epidemiology. Lancet 2003; 361: 859-864. (Pubitemid 36331852)
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ,. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96. (Pubitemid 351521864)
3. Oh WK, Kantoff PW,. Management of hormone refractory prostate cancer: Current standards and future prospects. J Urol 1998; 160: 1220-1229. (Pubitemid 29480485)
4. Hadaschik BA, Gleave ME,. Therapeutic options for hormone-refractory prostate cancer in 2007. Urol Oncol 2007; 25: 413-419. (Pubitemid 47362763)
5. Anderson JM, Cereijido M,. Tight junctions, 2nd edition. Boca Raton: CRC Press; 2001. pp. 1-18.
6. Tsukita S, Furuse M, Itoh M,. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2001; 2: 285-293. (Pubitemid 33676971)
7. Chen Y, Lu Q, Schneeberger EE, Goodenough DA,. Restoration of tight junction structure and barrier function by down-regulation of the mitogen-activated protein kinase pathway in ras-transformed Madin-Darby canine kidney cells. Mol Biol Cell 2000; 11: 849-862. (Pubitemid 30159306)
8. Li D, Mrsny RJ,. Oncogenic Raf-1 disrupts epithelial tight junctions via downregulation of occludin. J Cell Biol 2000; 148: 791-800.
9. Tobioka H, Isomura H, Kokai Y, Sawada N,. Polarized distribution of carcinoembryonic antigen is associated with a tight junction molecule in human colorectal adenocarcinoma. J Pathol 2002; 198: 207-212. (Pubitemid 35243878)
10. Soler AP, Miller RD, Laughlin KV, Carp NZ, Klurfeld DM, Mullin JM,. Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis 1999; 20: 1425-1431. (Pubitemid 29385425)
11. Dhawan P, Singh AB, Deane NG, No Y, Shiou SR, Schmidt C, Neff J, Washington MK, Beauchamp RD,. Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest 2005; 115: 1765-1776. (Pubitemid 40979715)
12. Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S,. Claudin-1 and-2: Novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 1998; 141: 1539-1550. (Pubitemid 28309169)
13. Turksen K, Troy TC,. Barriers built on claudins. J Cell Sci 2004; 117: 2435-2447. (Pubitemid 38877840)
14. Furuse M, Tsukita S,. Claudins in occluding junctions of humans and flies. Trends Cell Biol 2006; 16: 181-188.
15. Chiba H, Osanai M, Murata M, Kojima T, Sawada N,. Transmembrane proteins of tight junctions. Biochim Biophys Acta 2008; 1778: 588-600. (Pubitemid 351317799)
16. Väre P, Loikkanen I, Hirvikoski P, Vaarala MH, Soini Y,. Low claudin expression is associated with high Gleason grade in prostate adenocarcinoma. Oncol Rep 2008; 19: 25-31. (Pubitemid 351176127)
17. Landers KA, Samaratunga H, Teng L, Buck M, Burger MJ, Scells B, Lavin MF, Gardiner RA,. Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer. Br J Cancer 2008; 99: 491-501.
18. Morin PJ,. Claudin proteins in human cancer: Promising new targets for diagnosis and therapy. Cancer Res 2005; 65: 9603-9606. (Pubitemid 41541431)
19. Kominsky SL,. Claudins: Emerging targets for cancer therapy. Expert Rev Mol Med 2006; 8: 1-11. (Pubitemid 44184255)
20. Oliveira SS, Morgado-Díaz JA,. Claudins: Multifunctional players in epithelial tight junctions and their role in cancer. Cell Mol Life Sci 2007; 64: 17-28. (Pubitemid 46164492)
21. Sheehan GM, Kallakury BV, Sheehan CE, Fisher HA, Kaufman RP, Jr, Ross JS,. Loss of claudins-1 and-7 and expression of claudins-3 and-4 correlate with prognostic variables in prostatic adenocarcinomas. Hum Pathol 2007; 38: 564-569. (Pubitemid 46399893)
22. Katahira J, Inoue N, Horiguchi Y, Matsuda M, Sugimoto N,. Molecular cloning and functional characterization of the receptor for Clostridium perfringens enterotoxin. J Cell Biol 1997; 136: 1239-1247. (Pubitemid 27421912)
23. Smedley JG, III, Uzal FA, McClane BA,. Identification of a prepore large-complex stage in the mechanism of action of Clostridium perfringens enterotoxin. Infect Immun 2007; 75: 2381-2390. (Pubitemid 46744328)
24. Michl P, Buchholz M, Rolke M, Kunsch S, Löhr M, McClane B, Tsukita S, Leder G, Adler G, Gress TM,. Claudin-4: A new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology 2001; 121: 678-684. (Pubitemid 32822583)
25. Kominsky SL, Vali M, Korz D, Gabig TG, Weitzman SA, Argani P, Sukumar S,. Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4. Am J Pathol 2004; 164: 1627-1633. (Pubitemid 38529765)
26. Santin AD, Cané S, Bellone S, Palmieri M, Siegel ER, Thomas M, Roman JJ, Burnett A, Cannon MJ, Pecorelli S,. Treatment of chemotherapy- resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin. Cancer Res 2005; 65: 4334-4342. (Pubitemid 40775672)
27. Santin AD, Bellone S, Siegel ER, McKenney JK, Thomas M, Roman JJ, Burnett A, Tognon G, Bandiera E, Pecorelli S,. Overexpression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in uterine carcinosarcomas. Clin Cancer Res 2007; 13: 3339-3346. (Pubitemid 46944921)
28. Long H, Crean CD, Lee WH, Cummings OW, Gabig TG,. Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium. Cancer Res 2001; 61: 7878-7881. (Pubitemid 33049378)
29. Epstein JI, Allsbrook WC, Jr, Amin MB, Egevad LL, ISUP Grading Committee. The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 2005; 29: 1228-1242. (Pubitemid 41232997)
30. Sakai N, Chiba H, Fujita H, Akashi Y, Osanai M, Kojima T, Sawada N,. Expression patterns of claudin family on tight-junction proteins in the mouse prostate. Histochem Cell Biol 2007; 127: 457-462. (Pubitemid 46385574)
31. Heidenreich A, Aus G, Bolla M, Joniau S, Matveev VB, Schmid HP, Zattoni F,. European Association of Urology. EAU guidelines on prostate cancer. Eur Urol 2008; 53: 68-80. (Pubitemid 350166735)
32. Winkler L, Gehring C, Wenzel A, Müller SL, Piehl C, Krause G, Blasig IE, Piontek J,. Molecular determinants of the interaction between Clostridium perfringens enterotoxin fragments and claudin-3. J Biol Chem 2009; 284: 18863-18872.
33. Sonoda N, Furuse M, Sasaki H, Yonemura S, Katahira J, Horiguchi Y, Tsukita S,. Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: Evidence for direct involvement of claudins in tight junction barrier. J Cell Biol 1999; 147: 195-204. (Pubitemid 30211807)
34. Fujita K, Katahira J, Horiguchi Y, Sonoda N, Furuse M, Tsukita S,. Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein. FEBS Lett 2000; 476: 258-261. (Pubitemid 30410828)